Zhe Zhang MS

Suggest Changes
  • Citations Per Year
Learn More
Despite recent advances in earlier detection and improvements in chemotherapy, the 5-year survival rate of patients with metastatic colorectal carcinoma remains poor. Immunotherapy is a potentially(More)
  • 1